CStone Pharmaceuticals — Capital/Financing Update 2018

Mar 7, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [106 x 98] intentionally omitted <==

兗州煤業股份有限公司

YANZHOU COAL MINING COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China (“ PRC ”) with limited liability)

(Stock Code: 1171)

ANNOUNCEMENT OF COMPLETION OF THE ACQUISITION OF MDP'S WARKWORTH INTEREST

Reference is made to the update announcement and inside information announcement dated 12 June 2017 and the discloseable transaction and connected transaction announcement dated 26 September 2017 (the “ Announcements ”) of Yanzhou Coal Mining Company Limited (the “ Company ”) in relation to, among others, Yancoal Australia Limited (“ Yancoal Australia ”), a subsidiary controlled by the Company, was granted an irrevocable right to purchase MDP's Warkworth Interest with an exercise price of US$230 million (the “ Call Option ”), and Yancoal Australia exercised the Call Option to acquire MDP's Warkworth Interest (the “ Acquisition ”). Unless otherwise indicated, capitalized terms used in this announcement shall have the same meanings as those defined in the Announcements.

The Board is pleased to announce that, on 7 March 2018, Yancoal Australia completed the Acquisition. Upon completion of the Acquisition, the interest of Yancoal Australia in Warkworth Joint Venture increases to approximately 84.5%, and Yancoal Australia’s share of coal production from Mount Thorley Warkworth operations increases from 64.1% to 82.9%.

By order of the Board Yanzhou Coal Mining Company Limited Li Xiyong Chairman of the Board

Zoucheng, Shandong Province, the PRC 7 March 2018

As at the date of this announcement, the directors of the Company are Mr. Li Xiyong, Mr. Li Wei, Mr. Wu Xiangqian, Mr. Wu Yuxiang, Mr. Guo Dechun, Mr. Zhao Qingchun and Mr. Guo Jun, and the independent non-executive directors of the Company are Mr. Kong Xiangguo, Mr. Cai Chang, Mr. Poon Chiu Kwok and Mr. Qi Anbang.